Friday, October 06, 2017 9:31:44 AM
http://cellceutix.com/wp-content/uploads/2014/06/Prurisol-Presentation-for-Med-Derm-RD-Workshop_19Sep2016-u.pdf
The psoriasis market alone is growing from $7.49 Billion per year in 2014 to an estimated $9.02 Billion per year in 2019 and Prurisol will be used also for treatment of psoriatic arthritis, rheumatoid arthritis, multiple myeloma and various other diseases and conditions due to the FACT that Prurisol is a potent inhibitor of IL-20.
Good luck and GOD bless,
George
Recent IPIX News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
